Logo image of ALDLS.PA

D.L.S.I. (ALDLS.PA) Stock Fundamental Analysis

EPA:ALDLS - Euronext Paris - Matif - FR0010404368 - Common Stock - Currency: EUR

11.3  +0.1 (+0.89%)

Fundamental Rating

3

Taking everything into account, ALDLS scores 3 out of 10 in our fundamental rating. ALDLS was compared to 32 industry peers in the Professional Services industry. While ALDLS seems to be doing ok healthwise, there are quite some concerns on its profitability. ALDLS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALDLS had positive earnings in the past year.
In the past year ALDLS had a positive cash flow from operations.
ALDLS had positive earnings in 4 of the past 5 years.
Each year in the past 5 years ALDLS had a positive operating cash flow.
ALDLS.PA Yearly Net Income VS EBIT VS OCF VS FCFALDLS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

The Return On Assets of ALDLS (0.42%) is worse than 75.00% of its industry peers.
With a Return On Equity value of 0.85%, ALDLS is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
ALDLS has a Return On Invested Capital of 1.77%. This is in the lower half of the industry: ALDLS underperforms 71.88% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALDLS is significantly below the industry average of 11.28%.
Industry RankSector Rank
ROA 0.42%
ROE 0.85%
ROIC 1.77%
ROA(3y)2.62%
ROA(5y)2.01%
ROE(3y)5.21%
ROE(5y)4.07%
ROIC(3y)4.27%
ROIC(5y)3.78%
ALDLS.PA Yearly ROA, ROE, ROICALDLS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

ALDLS's Profit Margin of 0.23% is on the low side compared to the rest of the industry. ALDLS is outperformed by 75.00% of its industry peers.
In the last couple of years the Profit Margin of ALDLS has declined.
Looking at the Operating Margin, with a value of 1.10%, ALDLS is doing worse than 71.88% of the companies in the same industry.
ALDLS's Operating Margin has declined in the last couple of years.
The Gross Margin of ALDLS (99.44%) is better than 93.75% of its industry peers.
In the last couple of years the Gross Margin of ALDLS has remained more or less at the same level.
Industry RankSector Rank
OM 1.1%
PM (TTM) 0.23%
GM 99.44%
OM growth 3Y-24.87%
OM growth 5Y-23.75%
PM growth 3Y-46.24%
PM growth 5Y-35.32%
GM growth 3YN/A
GM growth 5Y0.73%
ALDLS.PA Yearly Profit, Operating, Gross MarginsALDLS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALDLS is destroying value.
ALDLS has about the same amout of shares outstanding than it did 1 year ago.
ALDLS has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALDLS has a worse debt to assets ratio.
ALDLS.PA Yearly Shares OutstandingALDLS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
ALDLS.PA Yearly Total Debt VS Total AssetsALDLS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ALDLS has an Altman-Z score of 2.92. This is not the best score and indicates that ALDLS is in the grey zone with still only limited risk for bankruptcy at the moment.
ALDLS has a Altman-Z score of 2.92. This is comparable to the rest of the industry: ALDLS outperforms 50.00% of its industry peers.
ALDLS has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALDLS (0.14) is better than 84.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 2.92
ROIC/WACC0.28
WACC6.38%
ALDLS.PA Yearly LT Debt VS Equity VS FCFALDLS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

ALDLS has a Current Ratio of 1.39. This is a normal value and indicates that ALDLS is financially healthy and should not expect problems in meeting its short term obligations.
ALDLS has a Current ratio of 1.39. This is in the better half of the industry: ALDLS outperforms 78.13% of its industry peers.
ALDLS has a Quick Ratio of 1.39. This is a normal value and indicates that ALDLS is financially healthy and should not expect problems in meeting its short term obligations.
ALDLS's Quick ratio of 1.39 is amongst the best of the industry. ALDLS outperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.39
ALDLS.PA Yearly Current Assets VS Current LiabilitesALDLS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

ALDLS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -86.52%.
The earnings per share for ALDLS have been decreasing by -36.49% on average. This is quite bad
ALDLS shows a small growth in Revenue. In the last year, the Revenue has grown by 3.59%.
Measured over the past years, ALDLS shows a decrease in Revenue. The Revenue has been decreasing by -1.81% on average per year.
EPS 1Y (TTM)-86.52%
EPS 3Y-44.72%
EPS 5Y-36.49%
EPS Q2Q%-32.69%
Revenue 1Y (TTM)3.59%
Revenue growth 3Y2.81%
Revenue growth 5Y-1.81%
Sales Q2Q%3.51%

3.2 Future

Based on estimates for the next years, ALDLS will show a very strong growth in Earnings Per Share. The EPS will grow by 125.73% on average per year.
ALDLS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.24% yearly.
EPS Next Y-23.81%
EPS Next 2Y125.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.94%
Revenue Next 2Y0.24%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALDLS.PA Yearly Revenue VS EstimatesALDLS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ALDLS.PA Yearly EPS VS EstimatesALDLS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2

2

4. Valuation

4.1 Price/Earnings Ratio

ALDLS is valuated quite expensively with a Price/Earnings ratio of 56.50.
Based on the Price/Earnings ratio, ALDLS is valued a bit more expensive than the industry average as 71.88% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 27.03. ALDLS is valued rather expensively when compared to this.
ALDLS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 56.5
Fwd PE N/A
ALDLS.PA Price Earnings VS Forward Price EarningsALDLS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

ALDLS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALDLS is cheaper than 96.88% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.74
ALDLS.PA Per share dataALDLS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

ALDLS's earnings are expected to grow with 125.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y125.73%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

ALDLS has a Yearly Dividend Yield of 3.51%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.89, ALDLS pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, ALDLS pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.51%

5.2 History

The dividend of ALDLS decreases each year by -8.17%.
Dividend Growth(5Y)-8.17%
Div Incr Years0
Div Non Decr Years2
ALDLS.PA Yearly Dividends per shareALDLS.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

205.04% of the earnings are spent on dividend by ALDLS. This is not a sustainable payout ratio.
DP205.04%
EPS Next 2Y125.73%
EPS Next 3YN/A
ALDLS.PA Yearly Income VS Free CF VS DividendALDLS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M
ALDLS.PA Dividend Payout.ALDLS.PA Dividend Payout, showing the Payout Ratio.ALDLS.PA Dividend Payout.PayoutRetained Earnings

D.L.S.I.

EPA:ALDLS (8/4/2025, 7:00:00 PM)

11.3

+0.1 (+0.89%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)07-24 2025-07-24
Earnings (Next)N/A N/A
Inst Owners7.02%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap28.70M
Analysts34.29
Price Target10.4 (-7.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.51%
Yearly Dividend0.4
Dividend Growth(5Y)-8.17%
DP205.04%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 56.5
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF 11.93
P/B 0.49
P/tB 1.4
EV/EBITDA 3.74
EPS(TTM)0.2
EY1.77%
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-1.55
FCFYN/A
OCF(TTM)0.95
OCFY8.38%
SpS83.41
BVpS22.98
TBVpS8.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.42%
ROE 0.85%
ROCE 3.4%
ROIC 1.77%
ROICexc 2.45%
ROICexgc 10.42%
OM 1.1%
PM (TTM) 0.23%
GM 99.44%
FCFM N/A
ROA(3y)2.62%
ROA(5y)2.01%
ROE(3y)5.21%
ROE(5y)4.07%
ROIC(3y)4.27%
ROIC(5y)3.78%
ROICexc(3y)7.43%
ROICexc(5y)6.52%
ROICexgc(3y)114.6%
ROICexgc(5y)367.19%
ROCE(3y)8.24%
ROCE(5y)7.29%
ROICexcg growth 3Y-81.68%
ROICexcg growth 5Y-23.58%
ROICexc growth 3Y-32.87%
ROICexc growth 5Y-25.93%
OM growth 3Y-24.87%
OM growth 5Y-23.75%
PM growth 3Y-46.24%
PM growth 5Y-35.32%
GM growth 3YN/A
GM growth 5Y0.73%
F-Score4
Asset Turnover1.79
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 1.34
Cap/Depr 169.66%
Cap/Sales 2.99%
Interest Coverage 250
Cash Conversion 39.59%
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.39
Altman-Z 2.92
F-Score4
WACC6.38%
ROIC/WACC0.28
Cap/Depr(3y)117.9%
Cap/Depr(5y)73.63%
Cap/Sales(3y)1.58%
Cap/Sales(5y)1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-86.52%
EPS 3Y-44.72%
EPS 5Y-36.49%
EPS Q2Q%-32.69%
EPS Next Y-23.81%
EPS Next 2Y125.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.59%
Revenue growth 3Y2.81%
Revenue growth 5Y-1.81%
Sales Q2Q%3.51%
Revenue Next Year-0.94%
Revenue Next 2Y0.24%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-62.19%
EBIT growth 3Y-22.75%
EBIT growth 5Y-25.14%
EBIT Next Year400%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-193.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.98%
OCF growth 3Y-49.34%
OCF growth 5Y-25.91%